
Sign up to save your podcasts
Or
Pfizer announced on Tuesday it will allow low and middle-income countries to make and distribute the company’s COVID-19 pill inexpensively. The move is an attempt to increase the global supply in 95 poorer nations.While the deal helps treat patients, the company has not made the same decision when it comes to its COVID-19 vaccine.
Axios Re:Cap host Felix Salmon is joined by Axios health care business reporter Bob Herman to discuss Pfizer’s decisions and the global ramifications.
4.3
690690 ratings
Pfizer announced on Tuesday it will allow low and middle-income countries to make and distribute the company’s COVID-19 pill inexpensively. The move is an attempt to increase the global supply in 95 poorer nations.While the deal helps treat patients, the company has not made the same decision when it comes to its COVID-19 vaccine.
Axios Re:Cap host Felix Salmon is joined by Axios health care business reporter Bob Herman to discuss Pfizer’s decisions and the global ramifications.
1,642 Listeners
4,326 Listeners
1,743 Listeners
8,651 Listeners
3,466 Listeners
111,154 Listeners
55,920 Listeners
2,259 Listeners
5,418 Listeners
5,914 Listeners
2,955 Listeners
2,021 Listeners
15,272 Listeners
4,367 Listeners
155 Listeners
1,149 Listeners
408 Listeners